Proteomic analysis of cholangiocarcinoma cell line. Srisomsap C*, Sawangareetrakul P, Subhasitanont P, Panichakul T, Keeratichamroen S, Lirdprapamongkol K, Chokchaichamnankit D, Sirisinha S, Svasti J. Proteomics. 2004 Apr;4(4):1135-44.

01 Apr 2004
0

Proteomic analysis of cholangiocarcinoma cell line.

Srisomsap C*, Sawangareetrakul P, Subhasitanont P, Panichakul T, Keeratichamroen S, Lirdprapamongkol K, Chokchaichamnankit D, Sirisinha S, Svasti J.

Proteomics. 2004 Apr;4(4):1135-44.

Tags

Share this

Related Posts

Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening. Ornnork N, Kiriwan D, Lirdprapamongkol K, Choowongkomon K, Svasti J, Eurtivong C*. J Mol Graph Model. 2020 Sep;99:107639.

Recent Posts